Addressing Inactive Kidney Transplant Waitlist Status Through Adapting a Tailored Psycho-Social-Environmental Program

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The purpose of this mixed methods study is to adapt CAPABLE as CAPABLE Transplant to accomplish two things: 1) To resolve barriers to being classified as active on the Kidney Transplant (KT) waitlist, 2) as a surgical prehabilitation intervention targeting the pre-frail/ frail KT waitlist population. It consists of two phases- an open label pilot and a randomized waitlist control trial, and 3) pilot test the feasibility and acceptability for CAPABLE Transplant in symptom and waitlist specific metrics amongst low-income active kidney transplant waitlist candidates.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Deceased Donor Waitlist

• ≥18 years old

• Community dwelling

• Current Inactive status or active and had been inactive in the last 18 months for cardiovascular disease, frailty, obesity, social support, mental health, incomplete testing OR Active on the waitlist and low-income

Locations
United States
Maryland
Johns Hopkins School of Nursing
RECRUITING
Baltimore
Contact Information
Primary
Samantha Curriero, MPH
scurrie6@jh.edu
4436991220
Time Frame
Start Date: 2025-01-25
Estimated Completion Date: 2026-07-01
Participants
Target number of participants: 43
Treatments
Experimental: Open Label Pilot
The Open Label Pilot will include testing the CAPABLE Transplant intervention with 3 individuals on the waitlist.
Experimental: Randomized Control Pilot- Intervention Arm
After the open label pilot, 20 participants will be randomized to the CAPABLE Transplant intervention. They will be assessed at baseline, after the 4 month intervention, and after the waitlist control arm.
Active_comparator: Randomized Control Pilot- Waitlist Control Arm
The waitlist control group, 20 participants, will receive the intervention after they have served as controls to the immediate treatment group, ensuring all participants have access to the intervention.
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Johns Hopkins University

This content was sourced from clinicaltrials.gov